Project Number ADDF-31 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2021 View Full Project Details for Validation of the Retinal Deep Phenotyping (TM) platform for the detection of the likely cerebral amyloid status to aid in the diagnosis of Alzheimer's disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 2. Imaging Biomarkers g. Retinal Imaging Researcher and Organization Principal Investigator Sylvestre, Jean-Philippe Principal Investigator Sylvestre, Jean-Philippe Awardee Organization Optina Diagnostics Awardee State Québec Contact PI Country Canada Project Detail FY Overall Cost $2,135,000 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
